This year’s scholars will focus their research on “what works” in real-world approaches to Long COVID and Type 2 Diabetes.
All News
Advertisement
GLP-1 drugs have proven effective in weight loss, but factors like insurance, what industry you work in, or gender, can all affect access
Advertisement
How technology and policy will redefine care.
A market analysis report from Grand View Research projects the AI diagnostics market size to grow at a CAGR of 24.60% through 2030.
News outlets report opposition to Robert F. Kennedy Jr. over vaccines, reproductive issues and more.
Advertisement
AP, Washington Post say order came down during President Donald Trump’s first full day in office.
Order goes far beyond removing DEI from the government, but is reaching into the private sector, as well
Prioritizing physician well-being while keeping patient care top of mind.
Just 25% of patients who self-monitor their heart health discuss the data with their doctors.
Advertisement
By helping family physicians, the new Congress and administration would bolster health care across the nation.
How telehealth organizations, med spas and other nontraditional providers can lead the charge on GLP-1 medications.
HHS-OIG’s recommended changes to the audit program aim to strengthen data protections.
One in four Americans experience functional decline by age 65, making fall risk management crucial for primary care practices.
Platform allows for highly precise detection of disease-specific cell-free DNA
ARS Pharmaceuticals is offering two cartons of neffy nasal spray to schools, including ongoing replacement doses
Most Americans believe that AI will improve health care outcomes, reduce costs, in the next 10 years
More than half of U.S. adults say AI will improve health outcomes and reduce costs, and three-quarters believe AI should play a role in health care education, survey says.
A new survey shows 11% of patients do not plan to get vaccinated, 54% are concerned about vaccine access—but 89% trust health care providers for vaccine information.
The potential CMS model would set a $2 copayment for common generic drugs in an effort to improve medication adherence.
The newly approved TriVerity combines a single-use test cartridge and the Myrna instrument to deliver results at the point of care, informing decisions related to antimicrobial therapy, reduce unnecessary hospital admissions and guide patient disposition.
Executive orders issued on first day of presidency impact various health initiatives
American Telemedicine Association publishes policy priorities for new president.
Surge in GLP-1RA use has researchers looking at all benefits of the drugs, but also the risk to the pancreas and kidneys
Global data demonstrates optimism, regional disparities and knowledge gaps that need to be addressed to increased public acceptance of emerging technologies.
Democrats claim credit, vow to fight against repeal; patient advocacy group offers critique.
Boston Scientific showcases promising data on heart treatments at AF Symposium 2025
Peter H. Reilly, North American health care practice leader and chief sales officer at HUB International, joins the show to discuss risks that medical practices face in the year ahead.
After running on a platform of bringing economic relief, President Trump must strengthen, not dismantle, existing programs.
Advertisement
Advertisement
Trending on Medical Economics
1
FDA grants Breakthrough Device status to Nephrodite's implantable continuous dialysis system
2
Epic monopoly on EHRs is hurting U.S. health care, Texas AG says
3
Flow Neuroscience wins first FDA approval for at-home brain-stimulation depression treatment
4
Incident-to billing in mental health: What physicians and other clinicians need to know about compliance and reimbursement
5
